Why Wall Street and Jim Cramer Think Danaher Stock Is 'Ready to Play'
Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does it too. Life sciences stocks are…
Jim Cramer
Jim Cramer has faith in Danaher's turnaround as life sciences come back to life
Life sciences stocks are experiencing a resurgence, and that's good news for Danaher. Connecting the dots with better times ahead…
We're raising our Eli Lilly price target – what a difference a quarter makes!
Eli Lilly shares rose Thursday after the drugmaker posted a strong third quarter, boosted by sales of its popular GLP-1…
We're downgrading it, considering the next step
Shares of Abbott Laboratories fell 3% on Wednesday after the diversified healthcare company turned in another less-than-stellar quarter. Revenue in…
We are buying the sauce in a stock and health science stock that has been reduced enough
We are buying 20 more Danaher shares at approximately $ 180 each. After Thursday's trade, Jim Cramer's charitable trust will…
Jim Cramer says that Eli Lilly's obesity pill could be more a “drug for life” than the shots
Do not count Eli Lilly's oral medication for obesity and diabetes yet, according to Jim Cramer de CNBC. That was…
This is the guide
ABBOTT Laboratories actions fell on Thursday after the diversified medical care company delivered a second solid quarter, but left investors…
Jim Cramer's 10 main things to see on the stock market on Monday
My 10 main things to see on Monday, May 19. 1. The bonds are crushing actions this morning, with the…
6 portfolio names committed to making large investments in the United States from Trump 2.0
Many of the largest American companies have pledged to invest billion dollars in the United States since President Donald Trump…
Danaher's quarterly results show signs of life, and the stock in difficulties is triggered
Danaher's actions rose more than 6% on Tuesday after the results of the first quarter of the medical care company…